Cardiac function and heart failure.
نویسنده
چکیده
coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. Am J Cardiol 2001;88:693–5. 12. Novaro GM, Tiong IY, Pearce GL, Lauer MS, Sprecher DL, Griffin BP. Effect of hydroxymethylglutaryl coenzyme A reductase inhibitors on the progression of calcific aortic stenosis. Circulation 2001;104: 2205–9. 13. Bellamy MF, Pellikka PA, Klarich KW, Tajik AJ, Enriquez-Sarano M. Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community. J Am Coll Cardiol 2002;40:1723–30. 14. Shavelle DM, Takasu J, Budoff MJ, Mao S, Zhao XQ, O’Brien KD. HMG CoA reductase inhibitor (statin) and aortic valve calcium. Lancet 2002;359:1125–6. 15. Pohle K, Maffert R, Ropers D, et al. Progression of aortic valve calcification: association with coronary atherosclerosis and cardiovascular risk factors. Circulation 2001;104:1927–32. 16. Antonini-Canterin F, Huang G, Cervesato E, et al. Do statins really slow the progression of aortic valve stenosis? A need for a prospective randomized trial (abstr). J Am Coll Cardiol 2003;41 Suppl A:497A. 17. Olsen M, Wachtell K, Bella JN, et al. The effect of losartan versus atenolol on aortic valve sclerosis: a LIFE study (abstr). J Am Coll Cardiol 2003;41 Suppl A:505A. 18. Diodato MD, Moazami N, Moon MR, et al. Does functional mitral regurgitation improve with isolated aortic valve replacement (abstr)? J Am Coll Cardiol 2003;41 Suppl A:503A. 19. Trichon BH, Coombs LP, O’Connor CM, Dullum M, Peterson ED. Outcomes after various surgical strategies for patients with severe ischemic cardiomyopathy and moderate mitral regurgitation (abstr). J Am Coll Cardiol 2003;41 Suppl A:504A. 20. Dohmen PM, Lembcke A, Dushe S, Hotz H, Konertz W. Up to two year’s performance using a tissue engineered pulmonary graft during the Ross procedure (abstr). J Am Coll Cardiol 2003;41 Suppl A:514A. 21. Cribier A, Eltchaninoff H, Tron C, et al. Percutaneous implantation of prosthetic heart valves: from animal model to first human implantation in calcific aortic stenosis (abstr). J Am Coll Cardiol 2003;41 Suppl A:508A. 22. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002;106:3006–8. 23. Boudjemline Y, Bonhoeffer P. Steps toward percutaneous aortic valve replacement. Circulation 2002;105:775–8.
منابع مشابه
Evaluation of Cardiac Mitochondrial Function by a Nuclear Imaging Technique using Technetium-99m-MIBI Uptake Kinetics
Mitochondria play an important role in energy production for the cell. The proper function of a myocardial cell largely depends on the functional capacity of the mitochondria. Therefore it is necessary to establish a novel and reliable method for a non-invasive assessment of mitochondrial function and metabolism in humans. Although originally designed for evaluating myocardial perfusion, 99mTc...
متن کاملComparison of the effects of intramyocardial and intravenous injections of human mesenchymal stem cells on cardiac regeneration after heart failure
Objective(s): Existing studies have demonstrated that intravenous and intramyocardial-administrated mesenchymal stem cells (MSCs) lead to tissue repair after cardiac disorders. We compared the efficiency of both administration methods.Materials and Methods: A rat model of isoproterenol-induced heart failure (ISO-HF) was established to co...
متن کاملRight ventricular Hemodynamic Alteration after Pulmonary Valve Replacement in Children with Congenital Heart Disease
Introduction: In patients who underwent surgery to repair Tetralogy of Fallot, right ventricular dilation from pulmonary regurgitation may be result in right ventricular failure, arrhythmias and cardiac arrest. Hence, pulmonary valve replacement may be necessary to reduce right ventricular volume overload. The aim of present study was to assess the effects of pulmonary valve replacement on rig...
متن کاملبررسی عوارض قلبی و مرگ و میر ناشی از آن در بیماران بتاتالاسمی ماژور در 10 سال گذشته در بیمارستان حضرت علیاصغر(ع)
Cardiac symptoms and premature death from cardiac causes are still major problem with beta thalassemia despite chelation therapy. Heart complications are the leading causes of mortality in the absence of effective iron chelation therapy. Many patients develop evidence of iron-induced myocardial damage with cardiac failure, cardiac arrhythmia, sudden death or death from progressive conge...
متن کاملThe cardioprotective effects of 4-O-(2″-O-acetyl-6″-O- p-coumaroyl-β-D-glucopyranosyl)-p-coumaric acid (4-ACGC) on chronic heart failure
The 4-ACGC isolated from BP was prepared to investigate the cardioprotective effects on attenuating chronic heart failure in vivo and in vitro. A chronic heart failure (CHF) rat model was established to investigate the cardioprotective effects of 4-ACGC. From this, several cardiac function indexes were recorded. The inflammatory markers including tumor necrosis factor-α (TNF-α), Interleukin-6 (...
متن کاملThe cardioprotective effects of 4-O-(2″-O-acetyl-6″-O- p-coumaroyl-β-D-glucopyranosyl)-p-coumaric acid (4-ACGC) on chronic heart failure
The 4-ACGC isolated from BP was prepared to investigate the cardioprotective effects on attenuating chronic heart failure in vivo and in vitro. A chronic heart failure (CHF) rat model was established to investigate the cardioprotective effects of 4-ACGC. From this, several cardiac function indexes were recorded. The inflammatory markers including tumor necrosis factor-α (TNF-α), Interleukin-6 (...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Journal of the American College of Cardiology
دوره 42 2 شماره
صفحات -
تاریخ انتشار 2003